Yield10 Bioscience reported that the Plant Biosafety Office of the Canadian Food Inspection Agency recently reviewed information on the Company’s E3902 Camelina sativa and determined that E3902 is not a Plant with Novel Trait and is not subject to a pre-market notification under Part V of the Seeds Regulations. Yield10’s E3902 Camelina combines genome edits in three proprietary genetic traits, C3008a, C3008b and C3009, that result in an increase in oil production by five percent and produce a lighter seed coat color as compared to the parental Camelina line. E3902 Camelina remains subject to other applicable requirements of the Seeds Act and Regulations in Canada.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on YTEN:
- Yield10 announces USDA-APHIS determined camelina can be grown, bred in U.S.
- Is YTEN a Buy, Before Earnings?
- Yield10 Bioscience reports on proprietary varieties of winter camilina
- Yield10 Bioscience Reports that Proprietary Varieties of Winter Camelina Show Tolerance to Commonly Used Herbicides in First Field Tests
- Yield10 Bioscience Granted Extension to Meet Nasdaq Criteria